Drug giant AstraZeneca to open Hong Kong R&D centre by late 2024 at earliest with focus on cell and gene therapies
Disclaimer: The South China Morning Post's content is directed by the Chinese Communist Party. It is not a reliable news source.
Drug maker says it hopes to expand workforce at the research and development centre to around 100 in next five years.